Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
COYA
#3480
Coya Therapeutics, Inc. - Common Stock
4.8
2
USD
-0.41%
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
-0.41%
Monthly Change
+17.27%
6 month change
-25.96%
Year Change
-9.91%
Previous Close
4.8
4
Open
4.8
2
Low
4.8
2
High
4.8
2
Volume
7
Markets
US Stock Market
Healthcare
COYA
Open full chart
Full chart
Financials
Overview
Statement
Statistics
Quarterly
Annual
Value
2022
2023
2024
2025
Current
Key stats
Total common shares outstanding
9.95 M
14.54 M
16.72 M
23.46 M
23.46 M
Valuation ratios
Enterprise value
62.08 M
77.38 M
57.49 M
89.23 M
59.99 M
Price to earnings ratio
-0.98
-8.81
-5.85
-4.57
-4.1
Price to sales ratio
—
11.79
24.57
12.21
10.03
Price to cash flow ratio
-1.66
-6.32
-8.49
-9.04
-6.32
Price to book ratio
-0.7
2.64
2.21
2.26
0.59
Enterprise value to EBITDA ratio
—
-9.83
-3.34
-3.96
-2.67
Profitability ratios
Return on assets %
-1.46
-0.19
-0.34
-0.42
-0.14
Return on equity %
1.46
-0.22
-0.38
-0.49
-0.15
Return on invested capital %
-3 242.01
-1 216.1
-1 746.24
-7 463.01
-2 484.48
Gross margin %
—
100
100
100
100
Operating margin %
—
-131.67
-485.35
-283.87
-3 042.13
EBITDA margin %
—
-131.22
-484.58
-283.52
-3 041.01
Net margin %
—
-133.08
-418.7
-267.14
-2 869.63
Liquidity ratios
Quick ratio
—
—
—
—
—
Current ratio
1.88
8.15
11.59
8.5
15.02
Inventory turnover
—
—
—
—
—
Asset turnover
—
0.24
0.08
0.16
0
Solvency ratios
Debt to assets ratio
1.54
—
—
—
—
Debt to equity ratio
-1.54
—
—
—
—
Long term debt to total assets ratio
-0.13
—
—
—
—
Long term debt to total equity ratio
0.13
—
—
—
—
Per share metrics
Operating cash flow per share
-2.79
-1.1
-0.68
-0.64
-0.75
EBIT per share
—
-0.78
-1.13
-1.35
-1.23
EBITDA per share
—
-0.77
-1.13
-1.35
-1.23
Total debt per share
5.01
—
—
—
—
Cash per share
2.29
3.21
2.52
2.8
2.24
Net current asset value per share
2.77
4.05
2.91
2.98
2.35
Tangible book value per share
-6.64
2.64
2.6
2.57
2.16
Working capital per share
1.3
3.56
2.66
2.63
2.2
Book value per share
-6.64
2.64
2.6
2.57
2.16
News
3 Best Stocks to Buy Today, 3/23/2026, According to Top Analysts - TipRanks.com
Coya Therapeutics, Inc. (COYA) Upgraded to Buy: What Does It Mean for the Stock?
H.C. Wainwright reiterates Buy rating on Coya Therapeutics stock with $18 target
Coya Therapeutics secures $11.1 million in private placement
Coya Therapeutics advances ALS and FTD clinical trials in 2026
H.C. Wainwright reiterates Buy rating on Coya Therapeutics stock at $18
Tracking David Einhorn’s Greenlight Capital Portfolio – Q3 2025 Update (NYSE:GRBK)
H.C. Wainwright reiterates Buy rating on Coya Therapeutics stock
H.C. Wainwright reaffirms Buy rating on Coya Therapeutics stock at $18 target
Coya Therapeutics closes $23 million public offering of common stock
Coya Therapeutics stock falls after pricing $20 million public offering
Coya Therapeutics prices $20 million public offering of common stock